User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 7 results.
    • Journal article
    Celyad's novel CAR T-cell therapy for solid malignancies.
    Lonez, Caroline Hendlisz, Alain Shaza, Leila Aftimos, Philippe Vouche, Michaël Donckier, Vincent Machiels, Jean-Pascal[UCL] Van den Eynde, Marc[UCL] Canon, Jean-Luc Carrasco, Javier Odunsi, Kunle Sahebjam, Solmaz Rottey, Sylvie Braun, Nathalie Verma, Bikash Gilham, David E Lehmann, Frédéric F (2018) Current research in translational medicine — Vol. 66, no.2, p. 53-56 (2018)
    • Journal article
    Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour types.
    Lonez, Caroline Verma, Bikash Hendlisz, Alain Aftimos, Philippe Awada, Ahmad Van Den Neste, Eric[UCL] Catala, Gaetan[UCL] Machiels, Jean-Pascal H[UCL] Piette, Fanny Brayer, Jason B Sallman, David A Kerre, Tessa Odunsi, Kunle Davila, Marco L Gilham, David E Lehmann, Frédéric F (2017) BMJ open — Vol. 7, no.11, p. e017075 (2017)
    • Journal article
    Chimeric Antigen Receptor-T Cells for Targeting Solid Tumors: Current Challenges and Existing Strategies.
    Springuel, Lorraine Lonez, Caroline Alexandre, Bertrand Van Cutsem, Eric Machiels, Jean-Pascal[UCL] Van Den Eynde, Marc[UCL] Prenen, Hans Hendlisz, Alain Shaza, Leila Carrasco, Javier Canon, Jean-Luc Opyrchal, Mateusz Odunsi, Kunle Rottey, Sylvie Gilham, David E Flament, Anne Lehmann, Frédéric F (2019) BioDrugs — Vol. 33, no. 5, p. 515-537 (2019)
    • Journal article
    A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors
    Limentani, Steven A Campone, Mario Dorval, Thierry Curigliano, Giuseppe de Boer, Richard Vogel, Charles White, Shane Bachelot, Thomas Canon, Jean-Luc Disis, Mary Awada, Ahmad Berlière, Martine[UCL] Amant, Frédéric Levine, Ellis Burny, Wivine Callegaro, Andrea de Sousa Alves, Pedro Miguel Louahed, Jamila Brichard, Vincent Lehmann, Frédéric F (2016) Breast Cancer Research and Treatment — Vol. 156, no.2, p. 319-330 (2016)
    • Journal article
    Association of homogeneous inflamed gene signature with a better outcome in patients with metastatic melanoma treated with MAGE-A3 immunotherapeutic.
    Baurain, Jean-François[UCL] Robert, Caroline Mortier, Laurent Neyns, Bart Grange, Florent Lebbe, Céleste Ulloa-Montoya, Fernando De Sousa Alves, Pedro Miguel Gillet, Marc Louahed, Jamila Jarnjak, Silvija Lehmann, Frédéric F (2018) ESMO Open — Vol. 3, no.5, p. e000384 [1-10] (2018)
    • Journal article
    Safety and immunogenicity of MAGE-A3 cancer immunotherapeutic with dacarbazine in patients with MAGE-A3-positive metastatic cutaneous melanoma: an open phase I/II study with a first assessment of a predictive gene signature.
    Grob, Jean-Jacques Mortier, Laurent D'Hondt, Lionel[UCL] Grange, Florent Baurain, Jean-François[UCL] Dréno, Brigitte Lebbe, Céleste Robert, Caroline Dompmartin, Anne Neyns, Bart Gillet, Marc Louahed, Jamila Jarnjak, Silvija Lehmann, Frédéric F (2017) ESMO open — Vol. 2, no. 5, p. e000203 [1-8] (2017)
    • Journal article
    CYAD-01, an autologous NKG2D-based CAR T-cell therapy, in relapsed or refractory acute myeloid leukaemia and myelodysplastic syndromes or multiple myeloma (THINK): haematological cohorts of the dose escalation segment of a phase 1 trial
    Sallman, David A Kerre, Tessa Havelange, Violaine[UCL] Poire, Xavier[UCL] Lewalle, Philippe Wang, Eunice S Brayer, Jason B Davila, Marco L Moors, Ine Machiels, Jean-Pascal[UCL] Awada, Ahmad Alcantar-Orozco, Erik M Borissova, Rossitza Braun, Nathalie Dheur, Marie-Sophie Gilham, David E Lonez, Caroline Lehmann, Frédéric F Flament, Anne (2023) The Lancet. Haematology — Vol. 10, no. 3, p. e191-e202 (2023)